Award recordCONTRACT

TEVA PHARMACEUTICALS USA, INC.

PIID VA797P16A0026· VA Staff Offices· NAC PHARMACEUTICALS 36P797· 6505 · DRUGS AND BIOLOGICALS· FY2016· $0 net obligations· UEI NEN9A34LRHJ5· PA

Description

2017 PL UPDATE CORRECTION

Base award description: BPA FOR CINQAIR

First action · last action
2016-09-14 · 2017-01-04
Transactions
3
First transaction's obligation
$0
Base + all options value (sum of deltas)
$12,500,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5980X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2016-09-14 · this action $0 · running total $0Modification P00001 · 2016-12-30 · this action $0 · running total $0Modification P00002 · 2017-01-04 · this action $0 · running total $0
  • Base2016-09-14+$0= $0
  • Mod P000012016-12-30+$0= $0
  • Mod P000022017-01-04+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-09-14+$0$0BPA FOR CINQAIR
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2016-12-30+$0$02017 PL UPDATES
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2017-01-04+$0$02017 PL UPDATE CORRECTION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NEN9A34LRHJ5)

AwardOffice · PSC / listingNet obligationsFY
36F79726D0125NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79723D0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36E79722D0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
VA797E17A0007NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2018
V797D70217NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017
VA797E17C0034NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017

Other recipients under 6505 from NAC PHARMACEUTICALS 36P797 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA797P17J0052MYLAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$6,169FY2017
VA797P17J0051MYLAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$17,881FY2017
VA797P17J0050MYLAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$72,904FY2017
VA797P17J0048KREMERS URBAN PHARMACEUTICALS INC.NAC PHARMACEUTICALS 36P797$1,225,936FY2017
VA797P17J0053EXELAN PHARMACEUTICALS INCNAC PHARMACEUTICALS 36P797$88,200FY2017

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797P16A0026_3600 · retrieved 2026-09-26.